Chao‐Ke Tang

8.5k total citations · 3 hit papers
145 papers, 6.4k citations indexed

About

Chao‐Ke Tang is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Chao‐Ke Tang has authored 145 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Surgery, 70 papers in Molecular Biology and 53 papers in Cancer Research. Recurrent topics in Chao‐Ke Tang's work include Cholesterol and Lipid Metabolism (72 papers), Peroxisome Proliferator-Activated Receptors (37 papers) and Cancer, Lipids, and Metabolism (31 papers). Chao‐Ke Tang is often cited by papers focused on Cholesterol and Lipid Metabolism (72 papers), Peroxisome Proliferator-Activated Receptors (37 papers) and Cancer, Lipids, and Metabolism (31 papers). Chao‐Ke Tang collaborates with scholars based in China, Canada and United States. Chao‐Ke Tang's co-authors include Xiao-Hua Yu, Xi‐Long Zheng, Dawei Zhang, Kai Yin, Yuchang Fu, Heng Li, Shilin Tang, Shangming Liu, Xiaohua Yu and Xin-Ping Ouyang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chao‐Ke Tang

142 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coronavirus disease 2019 (COVID-19): current status and future perspectives

2020 779 citations Heng Li, Xiao-Hua Yu et al. profile →
Foam cells in atherosclerosis

2013 615 citations Xiao-Hua Yu, Yuchang Fu et al. Clinica Chimica Acta profile →
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis

2021 153 citations Heng Li, Xiao-Hua Yu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chao‐Ke Tang China	43	2.5k	2.0k	1.5k	1.4k	864	145	6.4k
Paolo Parini Sweden	42	2.7k 1.1×	2.7k 1.3×	860 0.6×	795 0.6×	1.2k 1.3×	135	7.5k
Laurent Lagrost France	47	2.5k 1.0×	2.9k 1.4×	894 0.6×	828 0.6×	897 1.0×	186	6.9k
Robert J. Konrad United States	47	2.2k 0.9×	2.4k 1.2×	503 0.3×	1.6k 1.2×	394 0.5×	151	6.9k
Giuseppe Danilo Norata Italy	57	2.7k 1.1×	3.0k 1.5×	1.4k 0.9×	3.3k 2.4×	2.0k 2.3×	235	10.5k
John Cijiang He United States	61	3.9k 1.6×	766 0.4×	512 0.3×	1.3k 1.0×	945 1.1×	243	10.3k
David P. Hajjar United States	47	3.9k 1.6×	1.9k 0.9×	1.0k 0.7×	2.6k 1.9×	1.4k 1.7×	111	8.5k
Teresa Padró Spain	43	2.9k 1.1×	1.5k 0.7×	1.3k 0.8×	1.1k 0.8×	597 0.7×	197	7.2k
Koutaro Yokote Japan	47	4.6k 1.9×	2.8k 1.4×	1.4k 0.9×	883 0.7×	1.1k 1.3×	337	12.1k
Alexander N. Orekhov Russia	39	2.5k 1.0×	967 0.5×	658 0.4×	1.7k 1.3×	1.1k 1.3×	225	6.4k
Cheng Zhang China	43	2.6k 1.0×	761 0.4×	584 0.4×	836 0.6×	741 0.9×	216	6.2k

Countries citing papers authored by Chao‐Ke Tang

Since Specialization

Citations

This map shows the geographic impact of Chao‐Ke Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Ke Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Ke Tang more than expected).

Fields of papers citing papers by Chao‐Ke Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao‐Ke Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Ke Tang. The network helps show where Chao‐Ke Tang may publish in the future.

Co-authorship network of co-authors of Chao‐Ke Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Chao‐Ke Tang. A scholar is included among the top collaborators of Chao‐Ke Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao‐Ke Tang. Chao‐Ke Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yang, et al.. (2024). Ilexgenin A inhibits lipid accumulation in macrophages and reduces the progression of atherosclerosis through PTPN2/ERK1/2/ABCA1 signalling pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1869(7). 159533–159533. 3 indexed citations

Guo, Min, et al.. (2023). History and Development of ABCA1. Current Problems in Cardiology. 49(1). 102036–102036. 5 indexed citations

Li, Heng, et al.. (2023). Pax‐8: Molecular biology, pathophysiology, and potential pathogenesis. BioFactors. 50(3). 408–421. 1 indexed citations

Yuan, Wen, et al.. (2020). Long Non Coding RNA SNHG16 Facilitates Proliferation, Migration, Invasion and Autophagy of Neuroblastoma Cells via Sponging miR-542-3p and Upregulating ATG5 Expression. SHILAP Revista de lepidopterología. 1 indexed citations

Ou, Xiang, Jiahui Gao, Xiao-Hua Yu, et al.. (2019). Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(2). 158535–158535. 29 indexed citations

Zhang, Min, Liang Li, Wei Xie, et al.. (2016). Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation. Atherosclerosis. 248. 149–159. 65 indexed citations

Cayabyab, Francisco S., et al.. (2016). Sortilin: A novel regulator in lipid metabolism and atherogenesis. Clinica Chimica Acta. 460. 11–17. 36 indexed citations

Yao, Yan, Xin Zhang, Haipeng Chen, et al.. (2016). MicroRNA-186 promotes macrophage lipid accumulation and secretion of pro-inflammatory cytokines by targeting cystathionine γ-lyase in THP-1 macrophages. Atherosclerosis. 250. 122–132. 36 indexed citations

Wu, Jianfeng, Yanyan Tang, Min Zhang, et al.. (2014). Urotensin II increases foam cell formation by repressing ABCA1 expression through the ERK/NF-κB pathway in THP-1 macrophages. Biochemical and Biophysical Research Communications. 452(4). 998–1003. 21 indexed citations

10.

Yu, Xiaohua, Kai Wu, Xi‐Long Zheng, et al.. (2014). Hydrogen sulfide as a potent cardiovascular protective agent. Clinica Chimica Acta. 437. 78–87. 61 indexed citations

11.

Lv, Yun-Cheng, Kai Yin, Yuchang Fu, et al.. (2013). Posttranscriptional Regulation of ATP-Binding Cassette Transporter A1 in Lipid Metabolism. DNA and Cell Biology. 32(7). 348–358. 31 indexed citations

12.

Yu, Xiao-Hua, Kun Qian, Na Jiang, et al.. (2013). ABCG5/ABCG8 in cholesterol excretion and atherosclerosis. Clinica Chimica Acta. 428. 82–88. 154 indexed citations

13.

Yu, Xiao-Hua, Li-Jing Liu, Hong Qian, et al.. (2013). Apelin and its receptor APJ in cardiovascular diseases. Clinica Chimica Acta. 428. 1–8. 112 indexed citations

14.

Yin, Kai, Shilin Tang, Xiaohua Yu, et al.. (2013). Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE−/− mice possibly via activated STAT3-mediated upregulation of tristetraprolin. Acta Pharmacologica Sinica. 34(6). 837–846. 35 indexed citations

15.

Yin, Kai, Zhongcheng Mo, Guojun Zhao, et al.. (2011). Tristetraprolin-dependent Post-transcriptional Regulation of Inflammatory Cytokine mRNA Expression by Apolipoprotein A-I. Journal of Biological Chemistry. 286(16). 13834–13845. 48 indexed citations

16.

Xiao, Ji, Xiehong Liu, Meimei Liu, et al.. (2010). Ibrolipim increases ABCA1/G1 expression by the LXRα signaling pathway in THP-1 macrophage-derived foam cells. Acta Pharmacologica Sinica. 31(10). 1343–1349. 28 indexed citations

17.

Tang, Yaling, et al.. (2009). Mast cell degranulator compound 48–80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement. Chinese Medical Journal. 122(3). 319–325. 16 indexed citations

18.

Tang, Chao‐Ke. (2007). Roles of NPC1 and NPC2 in intracellular lipid homeostasis. Zhongguo bingli shengli zazhi. 1 indexed citations

19.

Zhang, Chi, Weidong Yin, Duan‐Fang Liao, et al.. (2006). NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs. Journal of Lipid Research. 47(9). 2055–2063. 28 indexed citations

20.

Tang, Chao‐Ke, HE Xiu-sheng, Guanghui Yi, et al.. (2003). The action of liver X receptor #alpha# on cholesterol efflux in THP-1 macrophage-derived foam cells. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 30(6). 940–944. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact